Concepedia

Hanan Alharthy

HA

Statistics

Publications

4

Citations

131

H-Index

4

Active since

2020

Affiliations

University of Maryland, Baltimore(Current)

University of Pennsylvania

Moffitt Cancer Center

Emory University

Huntsman Cancer Institute

Hanan Alharthy is an author at University of Maryland, Baltimore specializing in hematology, pharmacotherapy, and cancer research.

ORCID

Top concepts

Publications per year

2020–2023

4

Publications

4

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

Victor M. Orellana‐Noia, Daniel Reed, Ashley McCook et al. · Blood · 2021 · 91 citations · Full text

Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study

Moaath K. Mustafa Ali, Elizabeth M. Corley, Hanan Alharthy et al. · Frontiers in Oncology · 2022 · 19 citations · Full text

, , +14

CNS Prophylaxis during Front-Line Therapy in Aggressive Non-Hodgkin Lymphomas: Real-World Outcomes and Practice Patterns from 19 US Academic Institutions

Victor M. Orellana‐Noia, Daniel Reed, Jeremy Sen et al. · Blood · 2020 · 11 citations

Loncastuximab in High-Risk and Heavily-Pretreated Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real World Analysis from 21 US Centers

Emily C. Ayers, Viktoriya Zelikson, Ashwath Gurumurthi et al. · Blood · 2023 · 10 citations

1–4 of 4